APITOPE INTERNATIONAL NV - Belgium 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 1
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 1*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 6.000.000 240.000 1
2013 5.924.893 0 3.216.015 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMISCH ZIEKENHUIS LEIDEN1
ANOCCA AB1
BRISTOLMYERS SQUIBB COMPANY CORP1
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN1
FONDAZIONE PER L ISTITUTO DI RICERCA IN BIOMEDICINA1
GLAXOSMITHKLINE BIOLOGICALS1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
JANSSEN PHARMACEUTICA NV1
KAROLINSKA INSTITUTE1
KING'S COLLEGE LONDON1
KWS BIOTEST LIMITED1
MEDIZINISCHE UNIVERSITAET WIEN1
PFIZER LIMITED1
QUINTILES BENEFIT FRANCE INC1
SANOFIAVENTIS DEUTSCHLAND1
SEMMELWEIS EGYETEM1
THE UNIVERSITY OF QUEENSLAND1
UCB BIOPHARMA1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF GLASGOW1
UNIVERSITY OF NEWCASTLE UPON TYNE1

Constancy:

Total number of partners: 22
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 22
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2013-12-01"The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease." DAVIADcoordinator5.924.8934